Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 48

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 48
---
000 roles successfully transitioned as of the end of 2024, as well as positioning the GBC for continued success                                                                                                                                              |
| Ms. Foo                 |     |             |     | 150% |     | •  Led the continued strengthening of Commercial Operations teams and capabilities to enable the Company’s strategic and operations priorities, supporting strong performance in 2024   •  Advanced strategic capital deployment, physician engagement, and service line development across markets to support high-quality, high-acuity growth across care delivery services   •  Furthered enterprise initiatives in support of the Company’s efficiency agenda and data-driven operating model, including advanced analytics and AI enablement                                                                                                     |
| Ms. Arbour              |     |             |     | 125% |     | •  Decommissioned all legacy data centers, consolidating four sites to one with integrated secure software networks; commensurate with launching cloud-enabled telephony and secure wireless capabilities across acute care hospitals   •  Completed enterprise-wide deployment of Cybersecurity cloud software for risk management, identity protection, and AI-enabled security, industrializing protections across the Company   •  Further consolidation of the technology support model across Tenet, Conifer, USPI, and TPR with standard services, governance and operations, enabling efficiencies, measurable KPIs and consistent experience |

| 2025 PROXY STATEMENT |     | 53 |

Compensation Discussion & Analysis Quality and Compliance Modifier Following the completion of the fiscal year, the HR Committee also reviews (i) negative hospital events that occurred during the prior year, such as any patterns of serious safety events and multiple condition level deficiencies during surveys, noncompliance resulting in immediate jeopardy, “needs improvement” or “unsatisfactory” audit ratings, and (ii) positive compliance and quality events, such as optimal internal audit results, optimal clinical compliance scorecard audit results and Centers for Medicare & Medicaid Services zero citation surveys. Following its review of 2024 quality and compliance performance, the HR Committee determined that no modification (positive or negative) would apply to the 2024 AIP awards to the NEOs. 2024 AIP Payouts The table below shows target and actual AIP awards earned by each NEO for 2024.

| Named Executive Officer |     | Target     
 AIP Payout |   |           |     | Calculated AIP Payout |   |           |     | Individual  
 Performance 
 Multiplier  |